News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
Fresenius SE Bid for Pfizer (PFE)'s Pump Biz Stalled, Pfizer Seeking Other Attractive Offers 7/22/2016
FDA Rejects Valeant (VRX) Glaucoma Drug, Raises Concerns Over Manufacturing Issues 7/22/2016
400+ Women are Suing Drug Giant Merck & Co. (MRK) Over Unequal Pay 7/22/2016
Galenica (GALN.SW) to Acquire Bay Area's Relypsa (RLYP) for $1.53 Billion 7/21/2016
Drug Giant Merck & Co. (MRK) to Set Up Shop in South San Francisco 7/21/2016
In Effort to Reform, Struggling Theranos Hires New Chiefs to Help Pull It Out of Its Ditch 7/21/2016
Celgene (CELG) Exec Takes Leave to Work on Trump Campaign 7/21/2016
Struggling Aegerion (AEGR) Axes 13% of Workforce, Withdraws Cholesterol Drug from the EU 7/21/2016
GHO Capital Announces Acquisition Of Caprion (CAPR) 7/20/2016
Amgen (AMGN) and Merck KGaA (MKGAF.PK) Invest in Boston's Akili, Increasing Funding Round to $42.4 Million 7/20/2016
3 Biotech Stocks That Could Explode in the Next 12 Months 7/20/2016
Startup Bioz Launches With First Search Engine Built for Life Science Research 7/20/2016
SoCal's Ionis Pharma (IONS) Cuts GI Deal Worth $810 Million With Janssen Biotech (JNJ) 7/19/2016
Former Epizyme (EPZM) CEO Helms Fulcrum Therapeutics; New Startup Banks $55 Million Series A 7/19/2016
Genentech (RHHBY) Receives a Blow After Lymphoma Drug Flunks Phase III Test 7/19/2016
Why Drugmakers like Merck & Co. (MRK), Shire (SHPG) and AstraZeneca PLC (AZN) Leave Philadelphia for Boston 7/19/2016
Merck KGaA (MKGAF.PK) Starts Construction on $115 Million Life Sci Hub in Massachusetts 7/19/2016
R&D Logic Provides Fourth Dimension Solution to Life Science Finance Software Platform 7/19/2016
FDA Panel Divided on Valeant (VRX)'s Psoriasis Drug Suicide Risk 7/18/2016
3 Big Pharmas That Have Plenty of Cash to Pay Out Investors 7/18/2016
Employee Taken to Hospital After Genentech (RHHBY) Hazmat Spill in South San Francisco 7/18/2016
Pharma Bro Martin Shkreli Gets Trial Date, Couldn’t Wait to Play Pokémon Go After Hearing 7/18/2016
European Regulator Calls XBiotech (XBIT)'s Phase III Cancer Data Unreliable 7/15/2016
Merck & Co. (MRK) Plans to Open Microbiome R&D Site in Former Idenix (IDIX) Facility in Cambridge 7/15/2016
Gilead (GILD) Used Legal Loopholes to Avoid Paying $10 Billion in Taxes Last Year 7/14/2016
NanoString (NSTG) Expands; New Biotech Silverback Therapeutics Sets Up Shop 7/14/2016
Germany's Vetter Plans to Hire 300 to Staff New Facility in Illinois 7/14/2016
Amgen (AMGN) Inches Closer to Selling Cheaper Version of AbbVie (ABBV)'s Blockbuster Humira 7/13/2016
Theranos Says Elizabeth Holmes Will Remain CEO, But it May Stop All Lab Operations 7/13/2016
Boston Filmmaker Plans to Make a Movie About the Early Days of Vertex (VRTX) 7/13/2016
Good News for Gilead (GILD) as Zydelig Passes Safety Review Test Despite Trial Deaths 7/12/2016
Evelo and Epiva Merge to Become a Leading Immuno-Microbiome Platform Company 7/12/2016
3 Nauseating Clinical Trial Flops of 2016 So Far 7/12/2016
4 High-Quality Biotechs Trading Like Risky Startups 7/12/2016
This Neglected Big Pharma Stock Could be About to Explode 7/11/2016
Theranos CEO Elizabeth Holmes Banned from Operating a Lab for Two Years 7/11/2016
Congress Demands Theranos CEO Explain What Went Wrong 7/8/2016
AbbVie (ABBV)'s $175 Million Gamble Pays Off as Ablynx (ABLYF) RA Drug Meets Goal in Phase II Study 7/8/2016
BioMarin (BMRN) Shoots Up on Roche (RHHBY) Takeover Rumor 7/8/2016
2 Fallen Biotech Stocks Worth Chasing 7/8/2016
Investors Look to the Future of AbbVie (ABBV) Post-Patent Protection for Humira 7/8/2016
KaloBios (KBIO) Enters Deal to Buy Back Former CEO Martin Shkreli's Shares 7/8/2016
Pfizer (PFE)'s Growth Strategy: Turning to Smaller M&As 7/7/2016
Roche (RHHBY) to Slash Approximately 350 IT Jobs by End of 2017 7/7/2016
10 Biotech Stocks that Could Blow Up in Q3 7/6/2016
BIND Therapeutics (BIND) Stock Soars After Accepting Pfizer (PFE)’s ‘Stalking Horse’ Asset Bid 7/6/2016
XBiotech (XBIT)'s Colorectal Cancer Drug Claims Fall Apart, Shares Plummet 7/6/2016
285 Jobs at Risk as Biogen (BIIB) to Stop Producing Drugs at Its Cambridge Plant 6/30/2016
100+ Jobs Gone as Pfizer (PFE) to Shut Down Boulder Facility 6/28/2016
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK), Novartis AG (NVS) and Roche (RHHBY) React to Brexit and Its Possible Impact on Biotech 6/27/2016
British Trade Group Suspends Astellas (ALPMY) After Drugmaker Disguised the True Purpose of a Meeting Held for Doctors 6/27/2016
Takeda (TKPYY) Returns Certain Molecules, Products to Amgen (AMGN) 6/27/2016
Sanofi (SNY) Gears Up for Second Round of Innovation Awards Grants 6/27/2016
What Happens to Merck KGaA (MKGAF.PK) Jobs After the UK Voted Brexit 6/24/2016
Cambridge's Eleven Bio (EBIO) Pink Slips 70% of Workforce in Restructuring 6/24/2016
A Look into NW Bio (NWBO)'s Downfall: Bad Management or Short Sellers? 6/24/2016
Two Bay Area Startups Win Amgen (AMGN)'s Golden Ticket Award 6/24/2016
GE Healthcare Opens Up $27 Million, 500-Job Facility in Massachusetts 6/24/2016
Hedge Fund Exec Accused of Paying Former FDA Official for Inside Information Found Dead in Apparent Suicide 6/24/2016
Massachusetts-Based Radius Health (RDUS) Opens Up Shop in Philadelphia with Plans to Hire 100+ Employees 6/23/2016
31-Year-Old Rachel Haurwitz Helms Hot CRISPR-Based Biotech Firm Caribou Biosciences 6/23/2016
AstraZeneca PLC (AZN) Takes a $80 Million Hit as the CDC Says Flu Vaccine Flumist Does Not Work 6/23/2016
What Pfizer (PFE) Could Look Like If it Breaks Up 6/23/2016
Sanofi (SNY) Partners Successfully with UMass Boston in Undergraduate STEM Program 6/23/2016
Immunomedics (IMMU) CFO Steps Down, Stock Has Fallen Steadily Since ASCO Fiasco 6/22/2016
Kite Pharma (KITE) Opens Up New T-Cell Therapy Manufacturing Plant in California 6/22/2016
Donors from Top 15 Drug Firms Drop Cash onto Presidential Candidate Hillary Clinton 6/22/2016
3 Big Data Risks Pharma Should Fear 6/22/2016
Silicon Valley Tech Titan Sean Parker to Back First CRISPR Test 6/22/2016
Opko Health (OPK) Rockets on FDA Approval of Rayaldee Four Months Ahead of PDUFA Date 6/22/2016
Biogen (BIIB)'s Cambridge Manufacturing Move Means More Work for the 1,300 Workers in North Carolina 6/21/2016
3 Big Pharmas Investors Should Take a Look At 6/20/2016
Endocyte (ECYT) Co-Founder Resigns Effective Immediately as CEO, New Leader Named 6/20/2016
Theranos is Finally Going to Share Data on Its Blood Tests in August 6/17/2016
Scancell (SCNLF) Suspends Dosing in Melanoma Trial Due to Quality Issues 6/17/2016
Former FDA Official Charged in Alleged Securities Scheme for Tipping Off Hedge Fund 6/16/2016
As Theranos Gets Dumped by Walgreens, Rival Quest Diagnostics (DGX) Moves into More Safeway Locations 6/16/2016
Google (GOOG)'s Verily Taps Communications Chief to Craft Company Message and Battle Media Criticism 6/16/2016
Arena (ARNA) Board Terminates CMO Without Cause, Effective Immediately 6/15/2016
Shire (SHPG) Nabs Breakthrough Tags for Drug to Treat Rare Gastrointestinal Conditions 6/15/2016
Pfizer (PFE)-Backed Ziarco Exploring Sale, Deal Could Bring in $1 Billion+ 6/15/2016
New York Startup Rgenix Bags $33 Million, Gears Up to Push Drug Once-Shelved by GlaxoSmithKline (GSK) into Trial 6/15/2016
Struggling Chiasma Chops 33% of Workforce After FDA Drug Rejection 6/15/2016
Beleaguered Cambridge Drugmaker Aegerion (AEGR) Merges with QLT (QLTI) to Survive 6/15/2016
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected 6/14/2016
Infinity Pharma (INFI) to Eliminate 46 Researchers After Lymphoma Drug Disappoints in Study 6/14/2016
Intarcia to Move HQ Next Month, Plans to Double Workforce By End of 2017 6/14/2016
Mesoblast (MSB.AX) Stock Sinks 42% After Teva (TEVA) Withdraws from Heart Failure Trials 6/14/2016
Walgreens Breaks Ties With Theranos, Will Shutter All 40 Wellness Centers 6/13/2016
Struggling Eleven Bio (EBIO) Forges Deal Worth $270 Million with Pharma Giant Roche (RHHBY) 6/13/2016
Jennifer Lawrence Signs On to Play Elizabeth Holmes in Movie About Embattled Theranos 6/13/2016
Pfizer (PFE) Quietly Raised Drug Prices By an Average of 8.8% Last Week 6/10/2016
BIO2016: French Firm Biose to Open U.S. HQ in Cambridge to Look for Partners 6/10/2016
Biogen (BIIB)'s $8 Billion Market Cap Drop Makes Thermo Fisher Scientific (TMO) the New King in Massachusetts, But GE Corporation (GE)’s Coming to Town 6/10/2016
Could Google (GOOG)'s Verily be the Next Theranos? 6/9/2016
Top Alphabet Exec Defends Google (GOOG)'s Verily Amid Criticism 6/9/2016
Boston Scientific (BSX) Aims for Major Cost Reductions in Global Restructuring 6/9/2016
Valeant (VRX) Scrambles to Restructure Deal with Walgreens 6/9/2016
BIO2016: Ireland Still Attracting Biotech, Pharma Companies to Set up Shop 6/9/2016
BIO2016: Months After Infamous "Sexist" Biotech Party, LifeSci Advisors Finds New Ways to Showcase Women 6/9/2016
Federal Judge Reverses Merck & Co. (MRK)’s $200 Million Patent Win Against Gilead (GILD) Over False Testimony 6/9/2016
BIO2016: Pharma Business Models Are Predicted To Shift To Patient Outcomes And Value 6/8/2016
Boston's Ginkgo BioWorks Bags $100 Million to Buy a Whole Lot of Synthetic DNA, Inks Deals with Twist Bioscience and Gen9 6/8/2016
Embattled Theranos Catches a Break, Says Only 1% of Tests Have Been Voided or Corrected 6/7/2016
3 Bargain Pharma Stocks to Watch 6/7/2016
Theranos CEO Elizabeth Holmes Will Get to Keep Her Honorary Doctorate from Pepperdine University 6/7/2016
Lion Biotech Raises Approximately $100 Million and Names a New CEO 6/7/2016
Genentech (RHHBY), OSI Pharma (OSIP) to Fork Over $67 Million for Misleading Info About Cancer Drug Efficacy 6/7/2016
3 Bargain Biotech Stocks to Buy Right Now 6/6/2016
ASCO2016: Genentech (RHHBY)'s TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer 6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference 6/6/2016
BIO2016: Biologics Consulting Launches Clinical Trials Planning and Oversight Group 6/6/2016
Shire (SHPG) to Hire Up to 200 New Employees for Baxalta (BXLT)'s Kendall Square Research Center 6/3/2016
What’s at the Heart of Alnylam (ALNY)'s Company Culture? 6/3/2016
Trio of Execs that Saved Martin Shkreli's Old Company KaloBios (KBIO) Could Get $700,000 Award 6/3/2016
Abbott (ABT) Tries to Bail Out of $5.8 Billion Deal as Alere (ALR) Faces Bribery Probes, But it Won't Be Easy 6/3/2016
FDA Approves Biogen (BIIB) and AbbVie (ABBV)'s Once-Monthly MS Drug Zinbryta 6/2/2016
Bay Area's StemCells (STEM) to Cease Operations After Ending Mid-Stage Study 6/2/2016
Peregrine (PPHM) Nixes Planned Trials for Bavituximab, But Hints at a Future Trial with AstraZeneca PLC (AZN)’s Durvalumab 6/2/2016
Ionis Pharma (IONS)'s Pain Propels Alnylam (ALNY) to Gain $1.5 Billion in Market Cap 6/1/2016
Former Valeant (VRX) CEO Nabs $9+ Million Severance Deal and Consulting Role 6/1/2016
Jazz Pharma (JAZZ) Pays $1.5 Billion for Celator Pharma (CPXX) to Gain a Promising Leukemia Drug 6/1/2016
Merck & Co. (MRK), Pfizer (PFE) and Others Join Forces to Fight California Drug Price Control Ballot Initiative 5/31/2016
Embattled Valeant (VRX) Reportedly Spurned a Takeover Offer from Takeda (TKPYY)-TPG 5/31/2016
Walgreens' Execs Ignored Doubts in Theranos' Technology in Fear of Deal Crumbling 5/27/2016
Genentech (RHHBY)’s Gazyva Meets Primary Endpoint Early in Late-Stage Study 5/27/2016
Thermo Fisher Scientific (TMO) Expands into Pharma Market, Antes Up $4.2 Billion for FEI Company 5/27/2016
Only One Week After Voiding Two Years of Tests, Theranos Now Faces Consumer Class Action Lawsuit 5/27/2016
Ionis Pharma (IONS) Plummets After GlaxoSmithKline (GSK) Opts Not to Initiate Phase III Study for Amyloid Cardiomyopathy Drug 5/27/2016
Retired Gilead (GILD) Exec Returns as His Replacement Exits 5/26/2016
Count Celgene (CELG) and Gilead (GILD) as New Suitors to Acquire the Popular Medivation (MDVN) 5/26/2016
Sophiris Bio (SPHS) Slashes Workforce in Half as Firm Explores Strategic Options 5/25/2016
Novartis AG (NVS) CEO Attempts to Rebuild as Seven Execs Jump Ship in the Space of Five Months 5/25/2016
Sanofi (SNY) Loses Three Top Execs, Reshuffles Executive Committee 5/24/2016
French Authorties Blame Both Biotrial and Bial Over Fatal Drug Trial 5/24/2016
M&A Targets Pfizer (PFE) and Others Could be Eyeballing 5/24/2016
Novartis AG (NVS)'s Pharma Head Exits as Drug Business is Split into Two 5/24/2016
10 Biotech Stocks Analysts are Upbeat About in May 5/23/2016
Fearless Theranos Eyes Expansion Despite Dealing with One Setback After Another 5/23/2016
NeuralStem to Cut an Unknown Number of Jobs in Reorganization 5/20/2016
Journalist Criticizes ZIOPHARM Oncology (ZIOP.OB) as Its Own ‘Biotech Bubble’ Held Aloft by Ties to R.J. Kirk's Intrexon (XON) 5/20/2016
About 500 Kendall Square Baxalta (BXLT) Staffers in Limbo as Shire (SHPG) Merger Talks Drag On 5/20/2016
3 Life Science Stocks Short-Sellers are Wrong About 5/20/2016
Embattled Theranos Tosses Out Two Years of Edison Blood Test Results 5/20/2016
AstraZeneca PLC (AZN) Hands Out Pink Slips to Unknown Number of Contract Sales Reps 5/19/2016
Enterome Opens Up U.S Office in Kendall Square 5/19/2016
AstraZeneca PLC (AZN) CEO's Big Experiment and His Take on Keeping Employees on Edge 5/19/2016
3 Biotech Stocks Investors Should Pick Up in May 5/18/2016
Navidea (NAVB) Shakeup Continues as CEO Rick Gonzalez is Now Out 5/18/2016
New York Could Be Next Booming Bio Hub as Cellectis (ALCLS), Pfizer (PFE) and Eli Lilly (LLY) Set Up Shop There 5/18/2016
Catalyst Pharma (CPRX) Axes 30% of Workforce to Conserve Cash 5/18/2016
Biogen (BIIB) Aligns with Two Super Stars and Bags a Deal with REGENXBIO in Gene Therapy Push 5/17/2016
Journalist Claims Intrexon (XON) CEO is Untrustworthy, Compares Firm to Theranos 5/17/2016
Theranos COO Abruptly Resigns, Company Adds New Board Members 5/17/2016
Aduro Biotech (ADRO)'s Stock Craters After Pancreatic Cancer Drug Trial Misses Primary Endpoint 5/17/2016
Bay Area's KineMed Files for Chapter 11, Owes $1 Million+ to NIH, Gates and Others 5/16/2016
Gutsy Sanofi (SNY) to Nominate 8 Directors for Medivation (MDVN) Board, Files Pre-Merger Papers 5/13/2016
Federal Agencies Want to Know More About Clovis Oncology (CLVS)'s Rociletinib Data from Last Fall 5/13/2016
Valeant (VRX)'s New CEO Criticized By Man Who Succeeded Him at Perrigo (PRGO) 5/13/2016
Chiasma Chief Says Firm May Challenge FDA Over Rare-Disease Drug Rejection 5/12/2016
Genentech (RHHBY) May Owe Refunds to Some Healthcare Providers Over 340B Price Violations 5/12/2016
Allergan (AGN) Reworking Its Executive Team, Outlines $10 Billion Stock Buyback as Q1 Revenue Falls Short 5/12/2016
Another Director, Accounting Firm Quit Navidea (NAVB), Lender Tried to Freeze Its Bank Accounts 5/11/2016
Pernix (PTX) CEO Steps Down, Effectively Immediately 5/11/2016
Bay Area's Alexza Pharma (ALXA) Sold in $35 Million Deal 5/11/2016
San Diego's Sorrento (SRNE) Hires Advisors to Mull Over Strategic Options 5/10/2016
AstraZeneca PLC (AZN) Employees from Shuttered Facility Could be Relocated to Delaware 5/10/2016
RXi Pharma (RXII) to Explore Strategic Options, Including Possible M&A 5/10/2016
BioDelivery (BDSI) Consolidating the Sales Force Size in Cost-Cutting Move 5/10/2016
Wildcat Capital Calls for Ouster of Sorrento (SRNE)'s CEO, Accuses Firm of Squandering Assets and Destroying Shareholder Value 5/9/2016
A Look at 4 People Molding Kendall Square's Future 5/9/2016
Investors Concerned as Endo Pharma (ENDP) Mimics the Path of Valeant (VRX) 5/9/2016
Endo Pharma (ENDP) to Cut 740 Employees and Shakes Up U.S. Senior Management in Restructuring 5/9/2016
Clovis Oncology (CLVS) to Eliminate 35% of Workforce and Ends All Trials of Lung Cancer Drug Rociletinib 5/9/2016
Look Who Google (GOOG)'s Verily Is Hiring 5/6/2016
Amgen (AMGN) Rumored to be Another Medivation (MDVN) Suitor 5/6/2016
Apple (AAPL) Taps Former Google X Cofounder for Health Push 5/6/2016
10 Massachusetts Biotechs Devoting the Most Cash to R&D 5/6/2016
Look Who’s Profiting from Gilead (GILD)'s Sky-High Hepatitis C Drug Prices 5/6/2016
Investors Disappointed as Merck & Co. (MRK) Sales of Januvia and Remicade Fall Short 5/5/2016
Booming Bay Area Biotech NGM Plans Move to Vacant Site Once Meant for Amgen (AMGN) 5/5/2016
3 Bargain Biotechs to Buy 5/4/2016
IMS Health, Quintiles (Q) to Merge to Form $23 Billion Power House 5/4/2016
Backed by Celgene (CELG) and Novartis AG (NVS), IDEAYA Biosciences Raises $46 Million and Recruits an Arsenal Full of Industry Vets 5/4/2016
Delaware Employees Nervous Over AstraZeneca PLC (AZN)'s $1 Billion Cost-Cutting Plans 5/4/2016
Theranos Allegedly Sent Team of Five Lawyers to Wall Street Journal to Squash Story 5/4/2016
Federal Judge Reopens Gilead (GILD) Case Amid Allegations Former Merck & Co. (MRK) Scientist Lied 5/3/2016
Cambridge's BIND Therapeutics (BIND) Files for Chapter 11 and Reviews Strategic Alternatives 5/3/2016
North Carolina's NephroGenex (NRX) Files for Chapter 11 and Seeks Sale 5/2/2016
Federal Health Regulators Release Lightly Redacted Theranos Report with More Details 5/2/2016
Sienna Biopharma Launches with $34 Million and a Roster Full of Former Kythera (KYTH) Execs 5/2/2016
FDA Sued for Not Disclosing More Info on the Experts Determining the Fate of Drugs and Devices 4/29/2016
Vertex (VRTX) CEO Took a 23% Pay Cut in 2015 as Firm Overhauls Compensation Policies 4/29/2016
Life Science Real Estate Developer Lands $310 Million Construction Loan for Cambridge R&D Project 4/29/2016
Biogen (BIIB) Poaches Star Pfizer (PFE) Scientist as New R&D Chief 4/29/2016
Alnylam (ALNY) Breaks Ground on New $200 Million Manufacturing Facility in Massachusetts, Adding 150 Jobs 4/29/2016
NantKwest CEO's $329.7 Million Pay Package Might Make Him the Highest-Paid U.S. Executive 4/29/2016
Pennsylvania’s Inovio Pharma (INO) Doubles Workforce, Continues Hiring Spree 4/28/2016
Valeant (VRX)'s New CEO Will Make Over $500 Million if Stock Hits $270 By 2020 4/28/2016
Backed by Celgene (CELG), Bay Area Startup FLX Bio Bags $50 Million to Push Lead Drug into Clinic 4/28/2016



//-->